American Society of Hematology Guidelines for Diagnosing and Treating Anemia
According to the American Society of Hematology guidelines, anemia is diagnosed when hemoglobin levels fall below 135 g/L in adult males and 120 g/L in adult females, requiring a systematic evaluation of potential causes and appropriate treatment based on etiology. 1, 2
Diagnostic Approach
Initial Laboratory Evaluation
- Complete blood count (CBC) with red cell indices to classify anemia as microcytic, normocytic, or macrocytic 1, 2
- Reticulocyte count to assess bone marrow response to anemia 2, 3
- Iron studies including serum ferritin and transferrin saturation to evaluate iron status 1, 2
- Vitamin B12 and folate levels to rule out deficiencies 2, 4
- Kidney function tests to evaluate for renal disease as a potential cause 1
Classification of Anemia Based on Red Cell Indices
- Microcytic anemia (MCV < 80 fL): Consider iron deficiency, thalassemia, anemia of chronic disease, lead poisoning 1, 3
- Normocytic anemia (MCV 80-100 fL): Consider anemia of chronic disease, renal failure, endocrine disorders 1, 4
- Macrocytic anemia (MCV > 100 fL): Consider vitamin B12/folate deficiency, hypothyroidism, myelodysplasia 1, 3
Further Diagnostic Testing Based on Initial Classification
- For microcytic anemia: Iron profile workup (ferritin < 100 μg/L, transferrin saturation < 20% indicates iron deficiency) 1, 5
- For normocytic anemia: Evaluate creatinine, inflammatory markers (CRP) 1, 6
- For macrocytic anemia: TSH, vitamin B12, and folate levels 1, 4
Additional Testing When Indicated
- Hemolysis workup including direct Coombs test, lactate dehydrogenase, and peripheral blood smear if hemolysis is suspected 2, 7
- Bone marrow examination in cases of unexplained cytopenias or suspected myelodysplasia 1, 4
- Gastrointestinal evaluation (endoscopy, colonoscopy) in patients with iron deficiency anemia, particularly in men and postmenopausal women 1, 2
Treatment Approach
Iron Deficiency Anemia
- Oral iron supplementation as first-line therapy 8
- Intravenous iron for patients with intolerance to oral iron, chronic kidney disease with poor response to oral iron, or inflammatory bowel disease 8
- Identify and treat the underlying cause of iron deficiency 2
Anemia of Chronic Disease
- Treatment of the underlying condition is the primary management strategy 6
- Iron supplementation if concomitant iron deficiency is present 6
- Erythropoiesis-stimulating agents (ESAs) may be considered in severe or symptomatic anemia, particularly in chronic kidney disease 6, 8
Chemotherapy-Induced Anemia
- ESAs can be considered for patients with chemotherapy-associated anemia when hemoglobin decreases to less than 10 g/dL 1
- Carefully weigh the risks of thromboembolism in patients for whom ESAs are prescribed 1
- Red blood cell transfusion is an option depending on the severity of anemia or clinical circumstances 1
Red Blood Cell Transfusion
- Consider for severe, symptomatic anemia or hemodynamic instability 1, 2
- Decision should not be made strictly based on whether hemoglobin has reached a certain threshold 1
- Assessment should include individual patient characteristics, severity of anemia, presence and severity of comorbidities 1
Special Considerations
Monitoring
- Regular monitoring of hemoglobin levels, at least every three months in patients with chronic kidney disease 1, 8
- More frequent monitoring may be indicated in patients with diabetes due to higher prevalence of anemia 1
Population-Specific Considerations
- Standard definitions of anemia may not apply to certain populations, including pregnant or menstruating women, those living at high altitude, smokers, elderly individuals (≥70 years), non-Caucasian races, and those with chronic lung disease or hemoglobinopathy 1
Common Pitfalls
- Ferritin is an acute phase reactant and may be elevated in inflammatory states despite iron deficiency 6
- Failure to investigate the underlying cause of iron deficiency anemia, particularly in men and postmenopausal women 2
- Overreliance on a single parameter for diagnosis rather than considering the complete clinical and laboratory picture 3, 9